據報騰訊(00700.HK)遊戲打造遊戲創作AI全鏈路解決方案業務
內地遊戲行業人工智能(AI)競賽白熱化,據內媒報道,騰訊(00700.HK)(TCEHY.US)旗下騰訊遊戲打造一個名為「VISVISE」的遊戲創作AI全鏈路解決方案業務,其中包括由旗下產品效能部GoSkinning團隊打造的Auto LUV和裙擺AI等開發工具,並且各類AI遊戲工具正在緊鑼密鼓的開發中。
目前AI正成為騰訊遊戲業務新引擎。上月騰訊發布混元遊戲視覺生成平台,號稱是首個工業級 AIGC 遊戲內容生產引擎,能夠大幅優化遊戲資產生成與遊戲製作流程。
除騰訊外,米哈遊(miHoYo)和網易-S(09999.HK)(NTES.US)亦亮出「技術王牌」,加碼AI遊戲佈局。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.